---
description: 生物素相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
generated_at: '2026-02-24T20:08:09.751092+00:00'
grand_parent: 生物素
json_ld:
  '@context': https://schema.org
  '@graph':
  - '@id': https://supplement.weiqi.kids/reports/biotin/literature/2026-02#webpage
    '@type': WebPage
    dateModified: '2026-02-24'
    datePublished: '2026-02-24'
    description: 生物素相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    inLanguage: zh-TW
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    name: 生物素文獻薈萃 2026-02
    speakable:
      '@type': SpeakableSpecification
      cssSelector:
      - .article-summary
      - .speakable-content
      - .key-takeaway
      - .key-answer
      - .expert-quote
      - .actionable-steps li
      - .faq-answer-content
    url: https://supplement.weiqi.kids/reports/biotin/literature/2026-02
  - '@id': https://supplement.weiqi.kids#organization
    '@type': Organization
    alternateName: Supplement Intelligence
    contactPoint:
      '@type': ContactPoint
      contactType: customer service
      email: info@weiqi.kids
    logo:
      '@type': ImageObject
      height: 60
      url: https://supplement.weiqi.kids/assets/images/logo.png
      width: 600
    name: 保健食品情報系統
    sameAs:
    - https://github.com/weiqi-kids/agent.supplement-product
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids#website
    '@type': WebSite
    name: 保健食品情報系統
    potentialAction:
      '@type': SearchAction
      query-input: required name=search_term
      target: https://supplement.weiqi.kids/search?q={search_term}
    url: https://supplement.weiqi.kids
  - '@id': https://supplement.weiqi.kids/reports/biotin/literature/2026-02#article
    '@type': Article
    articleSection: 文獻薈萃
    author:
      '@id': https://supplement.weiqi.kids/about#person
      '@type': Person
      hasCredential:
      - '@type': EducationalOccupationalCredential
        credentialCategory: AI System
        description: 整合六大市場官方資料庫的 AI 分析系統
        name: AI 資料分析系統
      knowsAbout:
      - 保健食品市場分析
      - 膳食補充劑法規
      - 成分趨勢研究
      - 全球市場情報
      - 產品資料萃取
      name: 保健食品情報 AI
      url: https://supplement.weiqi.kids/about
    dateModified: '2026-02-24'
    datePublished: '2026-02-24'
    description: 生物素相關學術文獻彙整 2026-02，整理最新研究成果與證據等級分析。
    headline: 生物素文獻薈萃 2026-02
    inLanguage: zh-TW
    isAccessibleForFree: true
    isPartOf:
      '@id': https://supplement.weiqi.kids#website
    keywords: 生物素,文獻回顧,學術研究,證據分析
    mainEntityOfPage:
      '@id': https://supplement.weiqi.kids/reports/biotin/literature/2026-02#webpage
    publisher:
      '@id': https://supplement.weiqi.kids#organization
    wordCount: 496
  - '@type': BreadcrumbList
    itemListElement:
    - '@type': ListItem
      item: https://supplement.weiqi.kids
      name: 首頁
      position: 1
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/biotin
      name: 生物素
      position: 2
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/biotin/literature
      name: 文獻薈萃
      position: 3
    - '@type': ListItem
      item: https://supplement.weiqi.kids/reports/biotin/literature/2026-02
      name: 2026-02
      position: 4
  - '@id': https://supplement.weiqi.kids/reports/biotin/literature/2026-02#primaryimage
    '@type': ImageObject
    creditText: 保健食品情報系統
    height: 630
    license: https://creativecommons.org/licenses/by-nc/4.0/
    representativeOfPage: true
    url: https://supplement.weiqi.kids/assets/images/og-default.png
    width: 1200
layout: default
nav_order: 202602
parent: 文獻薈萃
title: 生物素文獻薈萃 2026-02
topic: biotin
total_articles: 627
---

# 生物素文獻薈萃報告 — 2026 年 2 月

## 摘要

本月共收錄 生物素 相關文獻 627 篇，其中 Level 1 證據（Meta-Analysis/Systematic Review）8 篇，RCT 2 篇。

## 證據等級分布

| 證據等級 | 文獻數 | 佔比 |
|----------|--------|------|
| Level 1 (Meta-Analysis/Systematic Review) | 8 | 1.3% |
| Level 2 (RCT) | 2 | 0.3% |
| Level 3 (Clinical Trial) | 0 | 0.0% |
| Level 4 (Observational) | 1 | 0.2% |
| Level 5 (Review/Case Report/Other) | 616 | 98.2% |

## 功效分類統計

| 功效分類 | 中文 | 文獻數 | 佔比 |
|----------|------|--------|------|
| other | 其他 | 350 | 55.8% |
| immune | 免疫調節 | 71 | 11.3% |
| anti_aging | 抗衰老 | 65 | 10.4% |
| cardiovascular | 心血管 | 51 | 8.1% |
| metabolic | 代謝 | 50 | 8.0% |
| energy | 活力 | 44 | 7.0% |
| musculoskeletal | 肌肉骨骼 | 40 | 6.4% |
| cognitive | 認知功能 | 36 | 5.7% |
| digestive | 消化 | 25 | 4.0% |
| skin | 皮膚 | 21 | 3.3% |
| sexual | 性功能 | 7 | 1.1% |

## 成分搭配統計

| 成分 | 文獻數 |
|------|--------|
| EPA | 96 |
| iron | 73 |
| NAC | 23 |
| fiber | 17 |
| collagen | 10 |
| stem cell | 8 |
| zinc | 6 |
| calcium | 6 |
| creatine | 5 |
| glutathione | 5 |

## 成分組合分析

以下列出最常被共同研究的成分組合：

| 成分組合 | 共同出現文獻數 |
|----------|---------------|
| EPA + iron | 14 |
| EPA + NAC | 5 |
| fiber + iron | 4 |
| EPA + fiber | 3 |
| collagen + fiber | 3 |
| glutathione + iron | 3 |
| exosome + exosomes | 3 |
| EPA + creatine | 2 |
| calcium + fiber | 2 |
| NAC + fiber | 2 |

## 成分功效分析

以下列出主要成分在各功效領域的研究文獻數：

| 成分 | 總文獻 | 其他 | 免疫調節 | 抗衰老 | 肌肉骨骼 | 皮膚 | 活力 |
|------|--------|--------|--------|--------|--------|--------|--------|
| EPA | 96 | 44 | 11 | 14 | 8 | 6 | 10 |
| iron | 73 | 39 | 13 | 8 | 5 | 3 | 3 |
| NAC | 23 | 12 | 3 | 1 | 1 | - | 4 |
| fiber | 17 | 7 | 2 | 2 | 4 | 3 | 2 |
| collagen | 10 | - | 5 | 2 | 2 | 10 | - |
| stem cell | 8 | 1 | 2 | 2 | 2 | 1 | - |
| zinc | 6 | 4 | - | 1 | - | - | 1 |
| calcium | 6 | 3 | - | 1 | 1 | - | 2 |

## 研究類型分布

| 研究類型 | 文獻數 | 佔比 |
|----------|--------|------|
| Meta-Analysis | 8 | 1.3% |
| Systematic Review | 0 | 0.0% |
| RCT | 2 | 0.3% |
| Clinical Trial | 0 | 0.0% |
| Observational | 1 | 0.2% |
| Review | 14 | 2.2% |
| Case Report | 12 | 1.9% |
| Other | 590 | 94.1% |

## 近期重要文獻

### Level 1 證據（Meta-Analysis / Systematic Review）

1. **[The association between toll-like receptor gene polymorphism and Helicobacter pylori infection risk: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41731753/)** — Medicine, 2026-02-20
   - 功效分類：other

2. **[Meta-Analysis of Refeeding Syndrome in Predicting the Risk of Occurrence in Critically Ill Patients.](https://pubmed.ncbi.nlm.nih.gov/41725858/)** — Journal of nutrition and metabolism, 2026-01-01
   - 功效分類：metabolic

3. **[Efficacy of blood copeptin level for the prediction of mortality of adult patients with sepsis: a meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41728017/)** — Frontiers in medicine, 2025-01-01
   - 功效分類：other

4. **[Central versus peripheral veno-arterial extracorporeal membrane oxygenation during lung transplantation: a systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41727507/)** — JHLT open, 2026-05-01
   - 功效分類：other

5. **[Comparative effectiveness of continuous positive airway pressure and glucagon-like peptide-1 receptor agonists in obstructive sleep apnea: A network meta-analysis of randomised trials.](https://pubmed.ncbi.nlm.nih.gov/41725443/)** — Diabetes, obesity & metabolism, 2026-02-23
   - 功效分類：cardiovascular, metabolic


### Level 2 證據（RCT）

1. **[A randomized, double-blind, placebo-controlled trial of olanzapine versus placebo plus ondansetron and dexamethasone for antiemetic prophylaxis in patients receiving oxaliplatin-, irinotecan-, or carboplatin-based chemotherapy.](https://pubmed.ncbi.nlm.nih.gov/41731226/)** — Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026-02-24
   - 功效分類：other

2. **[The Bioavailability of Xanthohumol in Humans and the Influence of Formulation and Dose: Randomized Controlled Trial Data.](https://pubmed.ncbi.nlm.nih.gov/41723719/)** — Molecular nutrition & food research, 2026-02-01
   - 功效分類：other



---

<div class="disclaimer" markdown="1">

**免責聲明**

本網站內容由 AI 自動生成，基於各國官方公開資料庫的產品登記資訊。
報告內容僅供參考，不構成醫療建議、投資建議或商業建議。
如有健康問題，請諮詢專業醫療人員。

產品統計以資料庫登記為準，不代表實際市場銷售狀況。
各國監管制度不同，跨國比較應考慮法規差異。

</div>
